APO RESEARCH · REPORT
Cardiovascular and Cerebrovascular AI-assisted Diagnosis
Selected research
Industry Research
Cardiovascular and Cerebrovascular AI-assisted Diagnosis Industry Research Report 2026
Market perspective
The global Cardiovascular and Cerebrovascular AI-assisted Diagnosis market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Cardiovascular and Cerebrovascular AI-assisted Diagnosis market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Cardiovascular and Cerebrovascular AI-assisted Diagnosis market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Cardiovascular and Cerebrovascular AI-assisted Diagnosis market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Cardiovascular and Cerebrovascular AI-assisted Diagnosis include Deepwise, Lepu Medical, NeuMiva, G K Healthcare, Sense Time, United Imaging, Infervision, Shukun and FOSUN AITROX. among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Cardiovascular and Cerebrovascular AI-assisted Diagnosis market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Cardiovascular and Cerebrovascular AI-assisted Diagnosis.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market by Company
Deepwise
Lepu Medical
NeuMiva
G K Healthcare
Sense Time
United Imaging
Infervision
Shukun
FOSUN AITROX
Cardiovascular and Cerebrovascular AI-assisted Diagnosis Segment by Type
Public Cloud
Private Cloud
Cardiovascular and Cerebrovascular AI-assisted Diagnosis Segment by Application
Hospital
Clinic
Imaging Center
Cardiovascular and Cerebrovascular AI-assisted Diagnosis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cardiovascular and Cerebrovascular AI-assisted Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cardiovascular and Cerebrovascular AI-assisted Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cardiovascular and Cerebrovascular AI-assisted Diagnosis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Cardiovascular and Cerebrovascular AI-assisted Diagnosis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Public Cloud
- Private Cloud
Applications
- Hospital
- Clinic
- Imaging Center
Companies covered
- Deepwise
- Lepu Medical
- NeuMiva
- G K Healthcare
- Sense Time
- United Imaging
- Infervision
- Shukun
- FOSUN AITROX
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Cardiovascular and Cerebrovascular AI-assisted Diagnosis by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Public Cloud
- 2.2.3 Private Cloud
- 2.3 Cardiovascular and Cerebrovascular AI-assisted Diagnosis by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Clinic
- 2.3.4 Imaging Center
- 2.4 Assumptions and Limitations
3 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Breakdown Data by Type
- 3.1 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Historic Market Size by Type (2021-2026)
- 3.2 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Forecasted Market Size by Type (2027-2032)
4 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Breakdown Data by Application
- 4.1 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Historic Market Size by Application (2021-2026)
- 4.2 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Perspective (2021-2032)
- 5.2 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Growth Trends by Region
- 5.2.1 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Historic Market Size by Region (2021-2026)
- 5.2.3 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Forecasted Market Size by Region (2027-2032)
- 5.3 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Dynamics
- 5.3.1 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Industry Trends
- 5.3.2 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Drivers
- 5.3.3 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Challenges
- 5.3.4 Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Cardiovascular and Cerebrovascular AI-assisted Diagnosis Players by Revenue
- 6.1.1 Global Top Cardiovascular and Cerebrovascular AI-assisted Diagnosis Players by Revenue (2021-2026)
- 6.1.2 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Revenue Market Share by Players (2021-2026)
- 6.2 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Cardiovascular and Cerebrovascular AI-assisted Diagnosis Head Office and Area Served
- 6.4 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Players, Product Type & Application
- 6.5 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Manufacturers Established Date
- 6.6 Global Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032)
- 7.2 North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country (2021-2026)
- 7.4 North America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032)
- 8.2 Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country (2021-2026)
- 8.4 Europe Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032)
- 9.2 Asia-Pacific Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032)
- 10.2 South America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country (2021-2026)
- 10.4 South America Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size (2021-2032)
- 11.2 Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Cardiovascular and Cerebrovascular AI-assisted Diagnosis Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Deepwise
- 12.1.1 Deepwise Company Information
- 12.1.2 Deepwise Business Overview
- 12.1.3 Deepwise Revenue in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Business (2021-2026)
- 12.1.4 Deepwise Cardiovascular and Cerebrovascular AI-assisted Diagnosis Product Portfolio
- 12.1.5 Deepwise Recent Developments
- 12.2 Lepu Medical
- 12.2.1 Lepu Medical Company Information
- 12.2.2 Lepu Medical Business Overview
- 12.2.3 Lepu Medical Revenue in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Business (2021-2026)
- 12.2.4 Lepu Medical Cardiovascular and Cerebrovascular AI-assisted Diagnosis Product Portfolio
- 12.2.5 Lepu Medical Recent Developments
- 12.3 NeuMiva
- 12.3.1 NeuMiva Company Information
- 12.3.2 NeuMiva Business Overview
- 12.3.3 NeuMiva Revenue in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Business (2021-2026)
- 12.3.4 NeuMiva Cardiovascular and Cerebrovascular AI-assisted Diagnosis Product Portfolio
- 12.3.5 NeuMiva Recent Developments
- 12.4 G K Healthcare
- 12.4.1 G K Healthcare Company Information
- 12.4.2 G K Healthcare Business Overview
- 12.4.3 G K Healthcare Revenue in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Business (2021-2026)
- 12.4.4 G K Healthcare Cardiovascular and Cerebrovascular AI-assisted Diagnosis Product Portfolio
- 12.4.5 G K Healthcare Recent Developments
- 12.5 Sense Time
- 12.5.1 Sense Time Company Information
- 12.5.2 Sense Time Business Overview
- 12.5.3 Sense Time Revenue in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Business (2021-2026)
- 12.5.4 Sense Time Cardiovascular and Cerebrovascular AI-assisted Diagnosis Product Portfolio
- 12.5.5 Sense Time Recent Developments
- 12.6 United Imaging
- 12.6.1 United Imaging Company Information
- 12.6.2 United Imaging Business Overview
- 12.6.3 United Imaging Revenue in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Business (2021-2026)
- 12.6.4 United Imaging Cardiovascular and Cerebrovascular AI-assisted Diagnosis Product Portfolio
- 12.6.5 United Imaging Recent Developments
- 12.7 Infervision
- 12.7.1 Infervision Company Information
- 12.7.2 Infervision Business Overview
- 12.7.3 Infervision Revenue in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Business (2021-2026)
- 12.7.4 Infervision Cardiovascular and Cerebrovascular AI-assisted Diagnosis Product Portfolio
- 12.7.5 Infervision Recent Developments
- 12.8 Shukun
- 12.8.1 Shukun Company Information
- 12.8.2 Shukun Business Overview
- 12.8.3 Shukun Revenue in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Business (2021-2026)
- 12.8.4 Shukun Cardiovascular and Cerebrovascular AI-assisted Diagnosis Product Portfolio
- 12.8.5 Shukun Recent Developments
- 12.9 FOSUN AITROX
- 12.9.1 FOSUN AITROX Company Information
- 12.9.2 FOSUN AITROX Business Overview
- 12.9.3 FOSUN AITROX Revenue in Cardiovascular and Cerebrovascular AI-assisted Diagnosis Business (2021-2026)
- 12.9.4 FOSUN AITROX Cardiovascular and Cerebrovascular AI-assisted Diagnosis Product Portfolio
- 12.9.5 FOSUN AITROX Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst